Navigating the Foreign Corrupt Practices Act for the Life Science Industry
10 December 2015
Past Event
Location
Web Conference
Partner David Simon will discuss the Foreign Corrupt Practices Act and its effect on the life sciences industry.
The webinar provides an in-depth overview of the significant risks involved when companies lack the management of compliance.
To watch a recording of the webinar, click here.
To watch a recording of the webinar, click here.
Related Services
Industry Teams
Practice Areas
Insights
Wisconsin Court of Appeals Enforces Knowledge Requirement for Preference Claims
13 September 2019
Wisconsin Appellate Law
District Court Sheds Light on Scope of IPR Estoppel
12 September 2019
PTAB Trial Insights
What CMS Rule On Affiliations Means For Health Providers
11 September 2019
Health Care Law Today
AseraCare 11th Circuit Case Holds Differences in Hospice Clinical Opinions Are Insufficient to Demonstrate Falsity Under the FCA
11 September 2019
Health Care Law Today
Sharon to Speak at USPTO’s Invention-Con 2019
13 September 2019
Foley Attorneys Named 2019 New York Metro Super Lawyers and Rising Stars
12 September 2019
Weisbein Quoted in Women’s Wear Daily About FTC Oversight of Influencer Marketing
11 September 2019
Women's Wear Daily
Neuberger Published in NALSC Newsletter About Litigation Perils Facing Professional Recruiters
Summer/Fall 2019
National Association of Legal Search Consultants Newsletter
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
BRG Healthcare Leadership Conference
06 December 2019
Washington, D.C.
CTeL Telehealth Fall Summit 2019
04-06 December 2019
Washington, D.C.
Navigating the Foreign Corrupt Practices Act for the Life Science Industry
Location
Web Conference